Found: 55
Select item for more details and to access through your institution.
Optimising time samples for determining area under the curve of pharmacokinetic data using non‐compartmental analysis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2019, v. 71, n. 11, p. 1635, doi. 10.1111/jphp.13154
- By:
- Publication type:
- Article
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.
- Published in:
- Journal of Extracellular Vesicles, 2017, v. 6, n. 1, p. N.PAG, doi. 10.1080/20013078.2017.1324730
- By:
- Publication type:
- Article
Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery.
- Published in:
- Journal of Extracellular Vesicles, 2017, v. 6, n. 1, p. N.PAG, doi. 10.1080/20013078.2017.1333882
- By:
- Publication type:
- Article
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 6, p. 1, doi. 10.1007/s11912-020-00916-9
- By:
- Publication type:
- Article
Inhibitors of Tubulin Assembly Identified through Screening a Compound Library.
- Published in:
- Chemical Biology & Drug Design, 2008, v. 72, n. 6, p. 513, doi. 10.1111/j.1747-0285.2008.00729.x
- By:
- Publication type:
- Article
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7066, doi. 10.3390/ijms23137066
- By:
- Publication type:
- Article
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 1, p. 61, doi. 10.1007/s10549-023-07223-4
- By:
- Publication type:
- Article
Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.56651
- By:
- Publication type:
- Article
Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.12470
- By:
- Publication type:
- Article
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231217976
- By:
- Publication type:
- Article
Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 5, p. 1053, doi. 10.1007/s11095-017-2123-5
- By:
- Publication type:
- Article
Preparation and Evaluation of a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules.
- Published in:
- Pharmaceutical Research, 2016, v. 33, n. 11, p. 2722, doi. 10.1007/s11095-016-1999-9
- By:
- Publication type:
- Article
Pharmacokinetics and tolerability of multiple‐day oral dosing of mycophenolate mofetil in healthy horses.
- Published in:
- Journal of Veterinary Internal Medicine, 2023, v. 37, n. 5, p. 1907, doi. 10.1111/jvim.16797
- By:
- Publication type:
- Article
The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 701, doi. 10.1111/bjh.13354
- By:
- Publication type:
- Article
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1400, doi. 10.1007/s10637-020-00895-5
- By:
- Publication type:
- Article
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 340, doi. 10.1007/s10637-019-00786-4
- By:
- Publication type:
- Article
Noncompartmental pharmacokinetics of three intravenous mycophenolate mofetil concentrations in healthy Standardbred mares.
- Published in:
- Veterinary Dermatology, 2023, v. 34, n. 3, p. 222, doi. 10.1111/vde.13109
- By:
- Publication type:
- Article
Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.613328
- By:
- Publication type:
- Article
Acetaminophen Pediatric Dose Selection: Caregiver Satisfaction Regarding the Antipyretic Efficacy of Acetaminophen in Children.
- Published in:
- Clinical Pediatrics, 2012, v. 51, n. 11, p. 1030, doi. 10.1177/0009922812456592
- By:
- Publication type:
- Article
Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats.
- Published in:
- AAPS Journal, 2020, v. 22, n. 4, p. 1, doi. 10.1208/s12248-020-00474-9
- By:
- Publication type:
- Article
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents.
- Published in:
- AAPS Journal, 2016, v. 18, n. 3, p. 737, doi. 10.1208/s12248-016-9876-3
- By:
- Publication type:
- Article
Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice.
- Published in:
- AAPS Journal, 2012, v. 14, n. 4, p. 872, doi. 10.1208/s12248-012-9401-2
- By:
- Publication type:
- Article
Characterization of Silvestrol Pharmacokinetics in Mice Using Liquid Chromatography-Tandem Mass Spectrometry.
- Published in:
- AAPS Journal, 2011, v. 13, n. 3, p. 347, doi. 10.1208/s12248-011-9273-x
- By:
- Publication type:
- Article
Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells.
- Published in:
- AAPS Journal, 2011, v. 13, n. 3, p. 357, doi. 10.1208/s12248-011-9276-7
- By:
- Publication type:
- Article
Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0040724
- By:
- Publication type:
- Article
Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013792
- By:
- Publication type:
- Article
Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 924, doi. 10.1111/bcp.13873
- By:
- Publication type:
- Article
Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1755, doi. 10.3390/cancers15061755
- By:
- Publication type:
- Article
A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 685, doi. 10.1007/s10637-012-9863-1
- By:
- Publication type:
- Article
A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 629, doi. 10.1007/s10637-010-9563-7
- By:
- Publication type:
- Article
PRMT5 as a druggable target for glioblastoma therapy.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 753, doi. 10.1093/neuonc/nox206
- By:
- Publication type:
- Article
DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo.
- Published in:
- Small, 2022, v. 18, n. 26, p. 1, doi. 10.1002/smll.202108063
- By:
- Publication type:
- Article
Establishing a clinical pharmacology fellowship program for physicians, pharmacists, and pharmacologists: a newly accredited interdisciplinary training program at the Ohio State University.
- Published in:
- Advances in Medical Education & Practice, 2014, v. 5, p. 191, doi. 10.2147/AMEP.S60986
- By:
- Publication type:
- Article
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 1, p. 9, doi. 10.21873/cgp.20360
- By:
- Publication type:
- Article
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
- By:
- Publication type:
- Article
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I trial of flavopiridol in relapsed multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 249, doi. 10.1007/s00280-013-2347-y
- By:
- Publication type:
- Article
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 291, doi. 10.1002/psp4.12611
- By:
- Publication type:
- Article
Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 11, p. 748, doi. 10.1002/psp4.12345
- By:
- Publication type:
- Article
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82252-x
- By:
- Publication type:
- Article
Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 8, p. 705, doi. 10.1007/s40262-013-0064-7
- By:
- Publication type:
- Article
XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 12, p. 2327, doi. 10.1002/mc.23121
- By:
- Publication type:
- Article
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 7, p. 1722, doi. 10.1002/mc.22626
- By:
- Publication type:
- Article
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1457, doi. 10.1002/ajh.25958
- By:
- Publication type:
- Article
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 327, doi. 10.1002/ajh.23946
- By:
- Publication type:
- Article
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 1, p. 19, doi. 10.1002/ajh.23568
- By:
- Publication type:
- Article
Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer.
- Published in:
- Scientific Reports, 2015, p. 12122, doi. 10.1038/srep12122
- By:
- Publication type:
- Article
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1334440
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 6, p. 789, doi. 10.1007/s40262-023-01240-8
- By:
- Publication type:
- Article